$3.07
0.010.33%
Last update: Nov 11, 4:00 PM
Lexeo Therapeutics Inc
LXEONASDAQ
Lexeo Therapeutics fell 66.4% from $9.12 to $3.06, behind the S&P 500's +11.2%. Its worst day was Jan 12 (−23.0%), and its low came Oct 14 at $2.63.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Lexeo Therapeutics shares fell 12.2%, while the S&P 500 rose 0.1%.
−12.2% · S&P 500 +0.1%
Lexeo Therapeutics closed at its highest level of the year, 16.6% above where the year started.
+2.7% · S&P 500 +0.6%
Story events cover the past 12 months · Times ET
Lexeo Therapeutics shares fell 23.0%, while the S&P 500 rose 0.2%.
−23.0%, the year's worst day · S&P 500 +0.2%
EPS of $-0.27 beat the $-0.31 estimate on $0.00 revenue.
+8.9% · S&P 500 +2.9%
EPS of $-0.25 beat the $-0.30 estimate on $0.00 revenue.
+5.0% · S&P 500 +0.2%
Lexeo Therapeutics shares rose 14.3%, while the S&P 500 rose 1.0%.
+14.3%, the year's best day · S&P 500 +1.0%
EPS of $-0.30 missed the $-0.28 estimate on $0.00 revenue.
+1.9% · S&P 500 +0.3%
Lexeo Therapeutics shares fell 13.5%, while the S&P 500 fell 0.7%.
−13.5% · S&P 500 −0.7%
Lexeo Therapeutics closed at its lowest level of the year, 71.2% below where the year started.
−4.0% · S&P 500 −1.1%
Where it ended: a close of $3.06 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.32).
Nothing in the past 12 months.
All LXEO dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for LXEO and SPY from Benzinga historical bars. Not investment advice.
